Cunningham V. Everett's most recent trade in Illumina Inc was a trade of 4,248 Common Stock done at an average price of $97.1 . Disclosure was reported to the exchange on July 5, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Illumina Inc | Everett V. Cunningham | SVP, Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 97.15 per share. | 05 Jul 2025 | 4,248 | 41,942 (0%) | 0% | 97.1 | 412,693 | Common Stock |
Arvinas Inc | Everett V. Cunningham | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2025 | 23,105 | 23,105 | - | - | Stock Option (right to buy) | |
Arvinas Inc | Everett V. Cunningham | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2025 | 16,025 | 26,045 (0%) | 0% | 0 | Common Stock | |
Illumina Inc | Everett V. Cunningham | SVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2025 | 10,620 | 10,620 | - | - | Performance Shares | |
Illumina Inc | Everett V. Cunningham | SVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2025 | 10,620 | 10,620 | - | - | Performance Shares | |
Illumina Inc | Everett V. Cunningham | SVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2025 | 9,103 | 46,190 (0%) | 0% | 0 | Common Stock | |
Arvinas Inc | Everett V. Cunningham | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 9,070 | 9,070 | - | - | Stock Option (right to buy) | |
Arvinas Inc | Everett V. Cunningham | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 5,899 | 10,020 (0%) | 0% | 0 | Common Stock | |
Exact Sciences Corp. | Everett V. Cunningham | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 30.02 per share. | 30 Apr 2024 | 708 | 47,178 (0%) | 0% | 30.0 | 21,254 | Common Stock |
Exact Sciences Corp. | Everett V. Cunningham | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2024 | 291 | 46,470 (0%) | 0% | 0 | Common Stock | |
Exact Sciences Corp. | Everett V. Cunningham | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 60.15 per share. | 30 Apr 2024 | 136 | 47,042 (0%) | 0% | 60.1 | 8,180 | Common Stock |
Exact Sciences Corp. | Everett V. Cunningham | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Feb 2024 | 5,291 | 48,591 (0%) | 0% | 0 | Common Stock | |
Exact Sciences Corp. | Everett V. Cunningham | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Feb 2024 | 5,291 | 15,876 | - | - | Restricted Stock Units | |
Exact Sciences Corp. | Everett V. Cunningham | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 59.32 per share. | 29 Feb 2024 | 2,412 | 46,179 (0%) | 0% | 59.3 | 143,080 | Common Stock |
Exact Sciences Corp. | Cunningham V. Everett | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2024 | 31,668 | 31,668 | - | - | Restricted Stock Units | |
Exact Sciences Corp. | Everett Cunningham V. | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2024 | 7,678 | 46,948 (0%) | 0% | 0 | Common Stock | |
Exact Sciences Corp. | Everett Cunningham V. | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2024 | 7,678 | 15,356 | - | - | Restricted Stock Units | |
Exact Sciences Corp. | V. Everett Cunningham | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 56.89 per share. | 26 Feb 2024 | 3,648 | 43,300 (0%) | 0% | 56.9 | 207,535 | Common Stock |
Exact Sciences Corp. | Everett V. Cunningham | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 2,711 | 40,620 (0%) | 0% | 0 | Common Stock | |
Exact Sciences Corp. | V. Everett Cunningham | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 59.78 per share. | 21 Feb 2024 | 1,350 | 39,270 (0%) | 0% | 59.8 | 80,703 | Common Stock |
Arvinas Inc | Everett V. Cunningham | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 12,787 | 12,787 | - | - | Stock Option (right to buy) | |
Arvinas Inc | Everett V. Cunningham | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 4,121 | 4,121 (0%) | 0% | 0 | Common Stock | |
Exact Sciences Corp. | Everett V. Cunningham | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 62.01 per share. | 01 Mar 2023 | 3,628 | 22,703 (0%) | 0% | 62.0 | 224,972 | Common Stock |
Exact Sciences Corp. | Everett V. Cunningham | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2023 | 7,677 | 26,331 (0%) | 0% | 0 | Common Stock | |
Exact Sciences Corp. | Everett V. Cunningham | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2023 | 7,677 | 23,034 | - | - | Restricted Stock Units | |
Exact Sciences Corp. | Everett V. Cunningham | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2023 | 21,167 | 21,167 | - | - | Restricted Stock Units | |
Arvinas Inc | Everett V. Cunningham | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2022 | 30,095 | 30,095 | - | - | Common Stock | |
Exact Sciences Corp. | Everett V. Cunningham | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Oct 2022 | 20,003 | 20,523 (0%) | 0% | 0 | Common Stock | |
Exact Sciences Corp. | Everett V. Cunningham | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Oct 2022 | 20,003 | 40,007 | - | - | Restricted Stock Unit | |
Exact Sciences Corp. | Everett V. Cunningham | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 31.37 per share. | 11 Oct 2022 | 16,872 | 18,654 (0%) | 0% | 31.4 | 529,275 | Common Stock |
Exact Sciences Corp. | Everett V. Cunningham | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Oct 2022 | 15,003 | 15,002 | - | - | Restricted Stock Unit | |
Exact Sciences Corp. | Everett V. Cunningham | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Oct 2022 | 15,003 | 35,526 (0%) | 0% | 0 | Common Stock | |
Exact Sciences Corp. | Everett V. Cunningham | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 47.41 per share. | 11 Oct 2022 | 520 | 520 (0%) | 0% | 47.4 | 24,653 | Common Stock |
Exact Sciences Corp. | Everett V. Cunningham | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2022 | 30,711 | 30,711 | - | - | Restricted Stock Units |